CNR2 and Alzheimer disease: Unfortunately, in a follow-up study in healthy controls and patients with Alzheimer’s disease (AD), decreased brain uptake of [11C]NE40 in AD patients compared with healthy control subjects was shown [26], even though upregulated expression of CB2 has been previously demonstrated in post mortem AD brain tissue [27].